Why is Moderna Inc important to traders?
Learn all about what Moderna is, its share trading hours, and how to trade Moderna share CFDs with Capital.com
Learn more about Moderna IncSpread | 0.80 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 0.6 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 120.36 |
Open | 120.2 |
1-Year Change | -0.97% |
Day's Range | 119.38 - 122.1 |
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 120.35 | 3.88 | 3.33% | 116.47 | 122.31 | 116.45 |
Jul 24, 2024 | 118.32 | -2.49 | -2.06% | 120.81 | 120.85 | 115.42 |
Jul 23, 2024 | 120.95 | -1.04 | -0.85% | 121.99 | 123.36 | 120.10 |
Jul 22, 2024 | 122.20 | 1.45 | 1.20% | 120.75 | 124.01 | 120.39 |
Jul 19, 2024 | 120.50 | 0.24 | 0.20% | 120.26 | 121.50 | 116.80 |
Jul 18, 2024 | 121.27 | -1.95 | -1.58% | 123.22 | 126.30 | 120.87 |
Jul 17, 2024 | 123.95 | -0.77 | -0.62% | 124.72 | 126.15 | 120.06 |
Jul 16, 2024 | 125.50 | 4.11 | 3.39% | 121.39 | 127.14 | 120.58 |
Jul 15, 2024 | 121.40 | -1.25 | -1.02% | 122.65 | 123.36 | 115.95 |
Jul 12, 2024 | 121.43 | -2.65 | -2.14% | 124.08 | 129.17 | 120.35 |
Jul 11, 2024 | 121.33 | 3.26 | 2.76% | 118.07 | 124.04 | 117.50 |
Jul 10, 2024 | 117.47 | 1.12 | 0.96% | 116.35 | 120.15 | 115.23 |
Jul 9, 2024 | 116.01 | -0.72 | -0.62% | 116.73 | 118.62 | 115.33 |
Jul 8, 2024 | 116.53 | -2.04 | -1.72% | 118.57 | 119.64 | 115.50 |
Jul 5, 2024 | 117.95 | 0.53 | 0.45% | 117.42 | 118.75 | 115.50 |
Jul 3, 2024 | 116.03 | -2.42 | -2.04% | 118.45 | 119.45 | 115.21 |
Jul 2, 2024 | 116.74 | 1.25 | 1.08% | 115.49 | 118.98 | 113.97 |
Jul 1, 2024 | 115.45 | -3.26 | -2.75% | 118.71 | 123.57 | 115.10 |
Jun 28, 2024 | 118.72 | -2.61 | -2.15% | 121.33 | 123.20 | 118.02 |
Jun 27, 2024 | 121.38 | -0.32 | -0.26% | 121.70 | 122.30 | 118.46 |
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Moderna (MRNA) is a North American clinical-stage biotechnology company. Headquartered in Cambridge, Massachusetts, it specialises in drug discovery and development, as well as vaccine technologies based on messenger RNA (mRNA). The company is working on therapeutics and vaccines for infectious, autoimmune, immuno-oncology and cardiovascular diseases.
Moderna has a number of strategic partnerships with industry-leading names, such as Vertex Pharmaceuticals (VRTX), AstraZeneca (AZN) and Merck & Co (MRK). In 2020, it also worked with Lonza Group (LONN) and Catalent (CTLT) to manufacture its Covid-19 vaccine candidate mRNA-1273. At the end of 2020, the company had 12 programmes in clinical trials and a total of 23 development candidates.
Moderna shares are listed on the Nasdaq Stock Market under the ticker symbol MRNA. The company is a constituent of the US Tech 100 Index.
Stay up-to-date with the latest market news and watch the Moderna share price live at Capital.com.
The company was founded in 2010 as Moderna Therapeutics, with the goal of commercialising the research of stem-cell biologist Derrick Rossi. Apart from Rossi, Moderna’s co-founders were Noubar Afeyan, Robert Langer and Kenneth Chien. In August 2018, the company’s name was changed to Moderna.
In November 2020, Moderna’s Covid-19 vaccine candidate, mRNA-1273, showed preliminary evidence of 94.1 per cent efficacy in preventing the disease in a Phase 3 trial. The results led to its submission for emergency use authorisation in the US, Canada and Europe.
In late November, the EU made a deal with Moderna for up to 160 million doses of its vaccine. In December, the US government exercised its option to buy an additional 100 million doses of Moderna’s mRNA-1273, bringing the confirmed order commitment to 200 million doses.
With Capital.com’s Moderna share price chart, you can not only quickly view the current MRNA stock quote, but also trace the company’s share value in historic terms.
Moderna’s long-awaited initial public offering (IPO) happened in December 2018, with the firm selling 26.3 million shares priced at $23 each. At the time, it was the biggest biotech IPO ever. Moderna raised over $600m, valuing the company at $7.5bn (£5.6bn, €6.2bn).
In 2020, MRNA stock has been one of the US market’s best performers. This was due to rising investor enthusiasm over the company’s promising Covid-19 vaccine candidate. After opening the year at $19.57, the MRNA share price was on a hike, peaking at $94.85 in mid July. Within a month, it had dropped to $54.23, but then the stock gained another upside momentum, with its price surging past $100 on November 16. On December 8, the stock closed the trading day at $169.86, representing a year-to-date gain of nearly 770 per cent.
You can go long or short on the company’s shares and trace all the latest ups and downs of the Moderna Inc. stock price using Capital.com’s proprietary trading platform.
Industry: | Biotechnology & Medical Research (NEC) |
200 Technology Sq
CAMBRIDGE
MASSACHUSETTS 02139-3578
US
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024Learn all about what Moderna is, its share trading hours, and how to trade Moderna share CFDs with Capital.com
Learn more about Moderna IncJoin the 630,000+ traders worldwide that chose to trade with Capital.com